Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TX › BEDFORD › TEXAS HEALTH HARRIS METHODIST HOSPITAL HURST-EULESS-BEDFORD

TEXAS HEALTH HARRIS METHODIST HOSPITAL HURST-EULESS-BEDFORD

NPI: 1104845015 · BEDFORD, TX 76022 · Ambulatory Surgical Clinic/Center · NPI assigned 07/19/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official MINCHER, JEFF controls 13+ related entities in our dataset. Read more

$3.57M
Total Medicaid Paid
85,283
Total Claims
77,566
Beneficiaries
70
Codes Billed
2020-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMINCHER, JEFF (SENIOR VP REVENUE CYCLE)
NPI Enumeration Date07/19/2006

Related Entities

Other providers sharing the same authorized official: MINCHER, JEFF

ProviderCityStateTotal Paid
TEXAS HEALTH HARRIS METHODIST HOSPITAL FORT WORTH FORT WORTH TX $13.83M
TEXAS HEALTH ARLINGTON MEMORIAL HOSPITAL ARLINGTON TX $8.23M
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS DALLAS TX $5.33M
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST FORT WORTH FORT WORTH TX $5.20M
TEXAS HEALTH PRESBYTERIAN HOSPITAL KAUFMAN KAUFMAN TX $4.09M
TEXAS HEALTH PRESBYTERIAN HOSPITAL DENTON DENTON TX $3.84M
TEXAS HEALTH HARRIS METHODIST HOSPITAL STEPHENVILLE STEPHENVILLE TX $3.69M
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO PLANO TX $2.32M
TEXAS HEALTH HARRIS METHODIST HOSPITAL CLEBURNE CLEBURNE TX $2.31M
TEXAS HEALTH HARRIS METHODIST HOSPITAL AZLE AZLE TX $2.14M
TEXAS HEALTH HARRIS METHODIST HOSPITAL ALLIANCE FORT WORTH TX $986K
TEXAS HEALTH PRESBYTERIAN HOSPITAL ALLEN ALLEN TX $965K
TEXAS HEALTH HOSPITAL FRISCO FRISCO TX $473K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 633 $34K
2021 19,930 $757K
2022 30,078 $1.21M
2023 23,948 $1.15M
2024 10,694 $427K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 8,738 8,097 $1.49M
99283 Emergency department visit for the evaluation and management, moderate severity 15,308 14,625 $767K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,693 2,630 $392K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6,797 6,568 $121K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,042 978 $114K
80053 Comprehensive metabolic panel 8,010 7,154 $90K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,871 1,796 $90K
87631 564 548 $66K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9,648 8,263 $64K
71045 Radiologic examination, chest; single view 2,569 2,413 $61K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 497 484 $44K
74177 Computed tomography, abdomen and pelvis; with contrast material 266 246 $37K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,680 1,527 $28K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 646 623 $27K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 409 398 $24K
99281 Emergency department visit for the evaluation and management, self-limited or minor 365 354 $18K
70450 Computed tomography, head or brain; without contrast material 503 476 $18K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 388 382 $13K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 258 248 $12K
76801 195 159 $12K
CP007 223 130 $9K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,349 1,243 $8K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 407 396 $8K
84703 1,381 1,296 $8K
81001 2,348 2,167 $6K
96375 Therapeutic injection; each additional sequential IV push 926 797 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,027 501 $5K
93976 110 103 $5K
84484 1,276 994 $4K
J7030 Infusion, normal saline solution , 1000 cc 2,093 1,721 $4K
84702 384 295 $4K
83690 1,322 1,209 $3K
80048 Basic metabolic panel (calcium, ionized) 676 530 $3K
96361 Intravenous infusion, hydration; each additional hour 468 424 $3K
81025 426 404 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 98 88 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 54 52 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 54 52 $1K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 71 67 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 13 13 $866.52
71046 Radiologic examination, chest; 2 views 21 21 $865.82
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 207 175 $778.44
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,290 1,116 $740.44
83880 54 50 $729.87
81003 408 394 $645.46
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 56 52 $634.06
83605 181 124 $573.99
86901 277 248 $539.47
83735 226 161 $509.66
87081 64 60 $342.89
84443 Thyroid stimulating hormone (TSH) 26 24 $282.50
J1885 Injection, ketorolac tromethamine, per 15 mg 570 541 $275.61
85610 153 145 $258.81
J2270 Injection, morphine sulfate, up to 10 mg 319 250 $257.17
94760 48 39 $214.02
96376 66 44 $202.58
87040 68 37 $202.09
J0696 Injection, ceftriaxone sodium, per 250 mg 88 80 $181.83
87086 Culture, bacterial; quantitative colony count, urine 15 13 $136.26
86850 14 14 $107.32
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 40 39 $53.56
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 42 30 $43.89
J1100 Injection, dexamethasone sodium phosphate, 1 mg 40 40 $40.51
85379 15 15 $37.31
J7510 Prednisolone oral, per 5 mg 68 68 $30.94
86900 14 13 $25.61
36415 Collection of venous blood by venipuncture 1,794 1,585 $23.70
J3010 Injection, fentanyl citrate, 0.1 mg 17 14 $17.40
J2060 Injection, lorazepam, 2 mg 12 12 $2.88
A9270 Non-covered item or service 1,937 1,711 $0.00